Cargando…
Differential expression of Cdk5-phosphorylated CRMP2 following a spared nerve injury
Effective treatment of high-impact pain patients is one of the major stated goals of the National Pain Strategy in the United States. Identification of new targets and mechanisms underlying neuropathic pain will be critical in developing new target-specific medications for better neuropathic pain ma...
Autores principales: | Moutal, Aubin, Ji, Yingshi, Bellampalli, Shreya Sai, Khanna, Rajesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310452/ https://www.ncbi.nlm.nih.gov/pubmed/32571373 http://dx.doi.org/10.1186/s13041-020-00633-1 |
Ejemplares similares
-
Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain
por: Moutal, Aubin, et al.
Publicado: (2018) -
Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides
por: Moutal, Aubin, et al.
Publicado: (2015) -
CRMP2 is necessary for Neurofibromatosis type 1 related pain
por: Moutal, Aubin, et al.
Publicado: (2017) -
Evaluation of edonerpic maleate as a CRMP2 inhibitor for pain relief
por: Moutal, Aubin, et al.
Publicado: (2019) -
Activity of T-type calcium channels is independent of CRMP2 in sensory neurons
por: Cai, Song, et al.
Publicado: (2019)